http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02062388-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a550ff69f07da1635b7ce6441e0d0b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a52d16771a4b078e91f4559c6f486dc0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007fceb4245757a4ab7dc964882a70ac |
| publicationDate | 2002-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02062388-A1 |
| titleOfInvention | Composition and method for potentiating drugs |
| abstract | A method of potentiating the activity of a drug which affects the central nervous system (CNS) comprising systemically administrating to a subject said drug together with an effective amount of a compound which affects peripheral chemoreceptors and, optionally, with an effective amount of a stimulator of osmoreceptors. Also disclosed are pharmaceutical compositions for systemic administration comprising a CNS drug together with the aforementioned compounds. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3558378-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006054294-A1 |
| priorityDate | 2001-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.